A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer Article

cited authors

  • Muscarella, Peter; Bekaii-Saab, Tanios; McIntyre, Kristi; Rosemurgy, Alexander; Ross, Sharona B.; Richards, Donald A.; Fisher, William E.; Flynn, Patrick J.; Mattson, Alicia; Coeshott, Claire; Roder, Heinrich; Roder, Joanna; Harrell, Frank E., Jr.; Cohn, Allen; Rodell, Timothy C.; Apelian, David; GI-4000 Pancreas Cancer Study Grp

authors

Publication Date

  • March 1, 2021

webpage

published in

category

keywords

  • K-ras
  • T cell response
  • clinical trial
  • immunotherapy
  • pancreas cancer

start page

  • 8

end page

  • 19

volume

  • 7

issue

  • 1